Viewing Study NCT01762202


Ignite Creation Date: 2025-12-25 @ 3:38 AM
Ignite Modification Date: 2026-02-26 @ 12:36 AM
Study NCT ID: NCT01762202
Status: COMPLETED
Last Update Posted: 2020-10-14
First Post: 2013-01-04
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Assessment of Efficacy and Safety of Front-line Fludarabine, Cyclophoshamide and Ofatumumab Chemoimmunotherapy in Young Patients With Chronic Lymphocytic Leukemia.
Sponsor:
Organization: